In October 2023, Edesa Biotech, Inc. (NASDAQ:EDSA) announced that Health Canada has approved the company’s plan to harmonize the trial designs in the U.S. and Canada for the ongoing Phase 3 clinical ...
FLORHAM PARK, N.J., June 24, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback